HIVMA praises passage of the HOPE Act, urges swift enactment into law

November 13, 2013, Infectious Diseases Society of America

The U.S. Congress took an important step Tuesday evening with House passage of the HIV Organ Policy Equity (HOPE) Act, which will allow research on donation of organs from deceased HIV-infected donors to HIV-infected recipients. Having been passed by the Senate in June, the bill is now positioned to move to the White House to be signed into law. The HOPE Act modernizes outdated federal law to reflect the current medical understanding of HIV infection and to allow for scientific research. As HIV clinicians and researchers, we applaud Congressional passage of the Act and look forward to its swift enactment after it is signed by the President.

For patients living with HIV, deceased donors with the same infection represent a unique source of organs. Passage of the HOPE Act will save the lives of hundreds of HIV-infected patients struggling with liver and kidney failure each year. Until enactment of the HOPE Act, research necessary to explore the feasibility of such transplants was banned under .

Currently, an estimated 6,500 people die each year while waiting for organ transplants. This legislation will significantly reduce that number for both HIV-infected and HIV-negative patients because of the larger pool of organs available. Passage of the HOPE Act will also reduce costs to Medicare for dialysis treatment of end-stage kidney disease, while protecting public health by maintaining provisions that are critical to safe organ procurement and allocation.

The HIV Medicine Association (HIVMA) applauds the HOPE Act's co-sponsors and supporters, in particular Senators Barbara Boxer (D-CA) and Tom Coburn (R-OK), and Representatives Lois Capps (D-CA-24th), Andy Harris (R-MD-1st) and Michael Burgess (R-TX-26th), and looks forward to the bill's enactment into law and to working with the administration to swiftly implement this life-saving measure. For more information, see HIVMA's related FAQ and policy statement.

Explore further: HIV-infected donors present novel source of organs for HIV-infected transplant candidates

Related Stories

HIV-infected donors present novel source of organs for HIV-infected transplant candidates

May 23, 2011
A new study published in the American Journal of Transplantation reveals that HIV-infected deceased donors represent a potentially novel source of organs for HIV-infected transplant candidates that could decrease waitlist ...

Mayo Clinic makes kidney and pancreas transplant available to HIV-infected patients

December 6, 2011
Mayo Clinic in Florida is now offering kidney and pancreas transplants to HIV positive patients with advanced kidney disease and diabetes. Evidence is now solid that HIV-positive patients have the same favorable outcome in ...

'High-risk' organs from deceased donors safe when screened with current methods

October 25, 2013
Approximately 10% of deceased donor kidneys are considered "high-risk" for infection (HIV, HCV, HBV) and disease transmission according to criteria set by the Centers for Disease Control and Prevention. But new research suggests ...

Nail fungus drug might help against HIV, study suggests

September 24, 2013
(HealthDay)—A common drug used to treat nail fungus may hold promise against HIV, the virus that causes AIDS, according to a new study.

Recommended for you

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

Researchers find clues to AIDS resistance in sooty mangabey genome

January 3, 2018
Peaceful co-existence, rather than war: that's how sooty mangabeys, a monkey species found in West Africa, handle infection by SIV, a relative of HIV, and avoid developing AIDS-like disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.